RecruitingNot ApplicableNCT05425615
Language Processing and TMS
Probing Language Processes Using Transcranial Magnetic Stimulation
Sponsor
Medical College of Wisconsin
Enrollment
135 participants
Start Date
Jun 5, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria5
- Diagnosed with left hemisphere stroke
- Consent date \>= 1 month after stroke onset
- Right-handed
- Fluent in English
- years of age or older
Exclusion Criteria18
- Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing
- Non-decisional per decisionality questionnaire or other clinical assessment
- Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease)
- A chronic medical condition that is not treated or is unstable
- Presence of
- cardiac stimulators or pacemakers or intracardiac lines
- neurostimulators
- medication infusion device
- any other implants near the scalp (e.g., cochlear implants) or in the eye
- metal in the body
- Pregnancy
- History of skull fractures, or skin diseases
- History of ongoing or unmanaged seizures or a family history of epilepsy
- Presence of factors that potentially decrease seizure thresholds
- On pro-convulsant medications
- Untreated Sleep deprivation or insomnia
- Ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users)
- History of dyslexia or other developmental learning disabilities
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETranscranial Magnetic Stimulation
Deymed DuoMag XT-100 rTMS
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05425615
Related Trials
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
NCT066159731 location
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
NCT034017621 location
Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
NCT073318961 location
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
NCT0640296811 locations
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT0506521663 locations